Abstract
Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. Omalizumab is the unique biologic treatment registered for asthma therapy in children. The clinical efficacy and safety of omalizumab treatment in the pediatric population has been extensively documented in specific trials and consistently expanded from real-life studies. In addition, new experimental evidence suggests that omalizumab may also interfere with the cellular and molecular mechanisms underlying airway remodeling. Novel investigational anti-IgE monoclonal antibodies with improved pharmacodynamic properties are in the pipeline, potentially offering alternative mechanisms of modulating IgE pathway.
The aim of this review is to update current knowledge on anti-IgE therapy in pediatric respiratory diseases.
Keywords: Allergic rhinitis, asthma, IgE, ligelizumab, MEDI4212, omalizumab, quilizumab, rhinosinusitis.
Current Respiratory Medicine Reviews
Title:An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases
Volume: 13 Issue: 1
Author(s): Amelia Licari , Riccardo Castagnoli, Elisa Panfili, Alessia Marseglia, Ilaria Brambilla and Gian Luigi Marseglia*
Affiliation:
- Department of Pediatrics, University of Pavia, Pavia,Italy
Keywords: Allergic rhinitis, asthma, IgE, ligelizumab, MEDI4212, omalizumab, quilizumab, rhinosinusitis.
Abstract: Anti-IgE treatment represents a major breakthrough in the therapeutic management of severe allergic asthma. Omalizumab is the unique biologic treatment registered for asthma therapy in children. The clinical efficacy and safety of omalizumab treatment in the pediatric population has been extensively documented in specific trials and consistently expanded from real-life studies. In addition, new experimental evidence suggests that omalizumab may also interfere with the cellular and molecular mechanisms underlying airway remodeling. Novel investigational anti-IgE monoclonal antibodies with improved pharmacodynamic properties are in the pipeline, potentially offering alternative mechanisms of modulating IgE pathway.
The aim of this review is to update current knowledge on anti-IgE therapy in pediatric respiratory diseases.
Export Options
About this article
Cite this article as:
Licari Amelia , Castagnoli Riccardo , Panfili Elisa , Marseglia Alessia , Brambilla Ilaria and Luigi Marseglia Gian *, An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases, Current Respiratory Medicine Reviews 2017; 13 (1) . https://dx.doi.org/10.2174/1573398X13666170616110738
DOI https://dx.doi.org/10.2174/1573398X13666170616110738 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery
Current Pharmaceutical Design Arylsulphones: A Promising Class of Non-Nucleoside Antiviral Agents
Current Medicinal Chemistry - Anti-Infective Agents Vascular Biomarkers in Asthma and COPD
Current Topics in Medicinal Chemistry Neuroprotective Mechanisms of Oxygen and Ethanol: A Potential Combination Therapy in Stroke
Current Medicinal Chemistry Epigenetics of Aging
Current Genomics Application of Radioisotopes in Inflammation
Current Medicinal Chemistry Editorial from Editor-in-Chief [Hot topic:Airway Hyperresponsiveness in Asthma: Are We there Yet?]
Current Respiratory Medicine Reviews Diagnosis and Management of Trauma to the Trachea and Bronchi
Current Respiratory Medicine Reviews Drug-Induced Phototoxicity; An Early In Vitro Identification of Phototoxic Potential of New Drug Entities in Drug Discovery and Development
Current Drug Safety Leukotriene A4 Hydrolase as a Target for Cancer Prevention and Therapy
Current Cancer Drug Targets Differential Action of Phytochemicals on Platelet Apoptosis: A Biological Overview
Current Medicinal Chemistry The Potential for Phospholipids in the Treatment of Airway Inflammation: An Unexplored Solution
Current Molecular Pharmacology Shigella Vaccine Development: Prospective Animal Models and Current Status
Current Pharmaceutical Biotechnology Food Fortification with Omega-3 Fatty Acids; Microencapsulation as an Addition Method
Current Nutrition & Food Science Growing up in the Web of Social Networking: Adolescent Development and Social Media
Adolescent Psychiatry Pharmacotherapy of Sickle Cell Disease in Children
Current Pharmaceutical Design Bronchial Asthma, Chronic Obstructive Pulmonary Disease and NF-κB
Current Medicinal Chemistry Advancement in Nanoparticle-based Biosensors for Point-of-care <i>In vitro</i> Diagnostics
Current Topics in Medicinal Chemistry Prioritizing Disease Genes by Using Search Engine Algorithm
Current Bioinformatics Cytokines and their Antagonists as Therapeutic Agents
Current Medicinal Chemistry